3
Shared Docs
3
Same-Page
6 / 3
Mentions
From: ' To: Lesley Groff Subject: Fwd: FOURIER: Significant LDL Reduction with Evolocumab Date: Fri, 24 Mar 2017 11:17:36 +0000 Lesley please forward to Jeffrey rs Rony
From: ' To: Lesley Groff Subject: Fwd: FOURIER: Significant LDL Reductio
ply-To: Cardiology Alert <I Email not displaying correctyNiaw it in your browser. FOURIER: Significant LDL Reduction with Evolocumab New data from the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) study. presented at the 2017 American College of Cardiology Scientific Session in Was
From: Lesley Groff To: Jeffrey Epstein <[email protected]> Subject: Fwd: FOURIER: Significant LDL Reduction with Evolocumab Date: Fri, 24 Mar 2017 11:18:31 +0000
From: Lesley Groff To: Jeffrey Epstein <[email protected]> Sub
y Alert < EFTA00447987 Entail not displaying coirectly?View it in your browser. FOURIER: Significant LDL Reduction with Evolocumab New data from the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) study, presented at the 2017 American College of Cardiology Scientific Session in Was
From: Lesley Groff To: "Dr. Rony + Catherine Shimony" Subject: Re: FOURIER: Significant LDL Reduction with Evolocumab Date: Fri, 24 Mar 2017 11:18:21 +0000 will d
From: Lesley Groff To: "Dr. Rony + Catherine Shimony" Subject: R
Reply-To: Cardiology Alert E— ail not displaying conectly?View it in your browser. FOURIER: Significant LDL Reduction with Evolocumab New data from the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) study, presented at the 2017 American College of Cardiology Scientific Session in Was
Entities connected to both Lesley Groff and the Further Cardiovascular Outcomes Research

Jeffrey Epstein
PERSON
Mount Sinai
ORGANIZATION
Harvard Medical School
ORGANIZATIONRony Shimony
PERSONIcahn School of Medicine at Mount Sinai
ORGANIZATIONManalapan
LOCATIONKeech AC
ORGANIZATIONAmerican Medical Communications
ORGANIZATIONMarc S. Sabatine
PERSONSabatine
PERSONGiugliano RP
PERSONEvolocumab
ORGANIZATIONAmerican College of Cardiology 2017 Scientific Session
ORGANIZATIONSabatine M. Primary
ORGANIZATIONBrigham and Women's Hospital
ORGANIZATION